U.S. Cannabis Experience Holds Promise for Canada

Posted on Categories: Knowledge CentreTags: , , , , ,

If Canada’s experience with legal recreational marijuana parallels what is taking place in U.S. states, we have much to anticipate in terms of entrepreneurial ferment, job creation, wealth expansion and boosted tax receipts.

Legal recreational marijuana has been the law of the land in Colorado for three and a half years, and a little more than three years in Washington. Oregon staggered its roll-out of recreational marijuana between 2015 and last year, Alaska’s and Nevada’s programs are up and running, and soon to follow are Massachusetts, Maine and the cannabis behemoth known as California.

And in Canada, we are marching towards nationwide legalization sometime next year.

Read more “U.S. Cannabis Experience Holds Promise for Canada”

Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.

Posted on Categories: Investor Relations

Vancouver, BC, August 10, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), completed its first two successful harvests earlier this month. Acreage Pharms, utilizing its pesticide free growing systems, anticipates two harvests to take place the first week of September.

Trevor Dixon, CEO of Acreage Pharms commented “The yields from both of the first two harvests exceeded expectations. The additional two harvests in the first week of September will utilize the entire grow space which will maximize yields and generate sufficient data to determine anticipated annual production rates. Acreage Pharms will be in a position to receive the license to sell once the QA team has analyzed the results of the third-party lab tests. This will be a significant milestone for Acreage Pharms.”

Read more “Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.”